Lv11
30 积分 2022-05-10 加入
The Association of TSLP and IL-4 with Patient-Reported Outcome Measures in Chronic Rhinosinusitis with Nasal Polyps
1小时前
待确认
Advances in Targeting HER2 across Cancer Subtypes – A Pan-tumor Approach
2天前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
2天前
已完结
Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes
8天前
已完结
CCL3+ neutrophil signature predicts response to neoadjuvant toripalimab plus chemotherapy in patients with hypopharyngeal squamous cell carcinoma: A phase II trial
9天前
已完结
Hitting the Mark — Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer
10天前
已完结
Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial
11天前
已完结
Neoadjuvant treatment of HER2-positive breast cancer: has the era of antibody–drug conjugates arrived?
11天前
已完结
Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial
26天前
已完结
皖公网安备34019202002308
